Investors eyeing Syndax Pharmaceuticals Inc. (SNDX) shares, currently priced at $21.36, may consider the January 2028 put option at a $13 strike, which offers a bid of $2.80. This equates to a potential 21.5% return based on the $13 commitment, translating to a 10.4% annualized rate of return. However, this strategy does not provide participation in SNDX’s upside unless the stock price falls significantly and the put option is exercised.
Syndax Pharmaceuticals’ trailing twelve-month volatility is calculated at 68%, indicating significant price fluctuations. Investors should weigh this volatility alongside their risk tolerance when considering the $13 put option. This analysis can assist in making informed decisions regarding the potential rewards against risks associated with the option strategy.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
